Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pulse Biosciences CS (PLSE)

Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pulse Biosciences CS 601 BRICKELL KEY DRIVE SUITE 1080 MIAMI FL 33131 USA

www.pulsebiosciences.com Employees: 75 P: 510-906-4600

Sector:

Medical

Description:

Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California.

Key Statistics

Overview:

Market Capitalization, $K 914,190
Enterprise Value, $K 796,150
Shares Outstanding, K 67,768
Annual Sales, $ 0 K
Annual Net Income, $ -53,590 K
Last Quarter Sales, $ 90 K
Last Quarter Net Income, $ -19,390 K
EBIT, $ -78,950 K
EBITDA, $ -77,770 K
60-Month Beta 1.80
% of Insider Shareholders 74.60%
% of Institutional Shareholders 76.95%
Float, K 17,213
% Float 25.40%
Short Volume Ratio 0.43

Growth:

1-Year Return -32.91%
3-Year Return 359.17%
5-Year Return -25.32%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 61.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 11/05/25
Next Earnings Date N/A
Earnings Per Share ttm -1.09
EPS Growth vs. Prev Qtr -3.57%
EPS Growth vs. Prev Year -38.10%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PLSE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -67.70%
Return-on-Assets % -58.89%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 10,347.85
Price/Cash Flow N/A
Price/Book 9.43
Book Value/Share 1.38
Interest Coverage -1.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar